Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2009
12/23/2009WO2009152995A1 Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
12/23/2009WO2009152824A1 Heterocyclic derivatives as iap binding compounds
12/23/2009WO2009152735A1 Histone deacetylase inhibitors and uses thereof
12/23/2009WO2009152647A1 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent
12/23/2009WO2008155140A8 Alkynylpyrimidines as tie2 kinase inhibitors
12/23/2009EP2135873A2 Chemical coupling process with a phenyl boronic acid derivative
12/23/2009EP2135865A1 Substituted 1-(diazinyl)pyrazol-4-yl acetic acids, method for their production and their use as herbicides and plant growth regulators
12/23/2009EP2135620A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
12/23/2009EP2134703A1 Amide derivatives as calcium channel blockers
12/23/2009EP2134701A1 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
12/23/2009EP2134695A1 Inhibitors of the hedgehog pathway
12/23/2009EP2134693A2 Metalloprotease inhibitors containing a heterocyclic moiety
12/23/2009EP2134690A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
12/23/2009EP2134687A1 Piperazine and piperidine mglur5 potentiators
12/23/2009EP2134686A1 Piperidinones useful in the treatment of inflammation
12/23/2009EP2134684A2 7-substituted indole mcl-1 inhibitors
12/23/2009EP2134683A2 Novel inhibitors hepatitis c virus replication
12/23/2009EP2134345A2 Triazolquinolonic derivatives with antimycobacterial activity
12/23/2009EP2134176A1 Compounds and methods for enhancing mhc class ii therapies
12/23/2009EP2134175A1 Inhibitors of akt activity
12/23/2009EP1919896B1 Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands.
12/23/2009EP1817309B1 Acetamide compounds as fungicides
12/23/2009EP1720859B1 Chemokine receptor antagonists
12/23/2009EP1709037B1 Hiv protease inhibiting sulfonamides
12/23/2009EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors
12/23/2009EP1259487B1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
12/23/2009CN101611029A Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl) phenoxy)methyl)quinoline
12/23/2009CN101611028A Substituted oxindole derivatives and their use as vasopressin receptor ligands
12/23/2009CN101611027A Indol-2-yl-piperazin-1-yl-methanone derivatives
12/23/2009CN101611026A Processes for the preparation of (3R, 4R) -N- (4 -chlorophenyl) -1- (2, 2-difluoroethyl) -N' - [2-fluoro-4- (2-oxo-1 (2H) -pyridinyl) phenyl] -3, 4-pyrrolidinedicarboxamide
12/23/2009CN101611025A 5,6-ring annulated indole derivatives and methods of use thereof
12/23/2009CN101611024A Crystalline forms of aryl-substituted pyrazole-amide compounds
12/23/2009CN101611018A Heterocyclyc sulfonamides having Edg-I antagonistic activity
12/23/2009CN101611015A Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
12/23/2009CN101611014A Acylaminopyrazoles as FGFR inhibitors
12/23/2009CN101611012A Cycloalkylamine substituted isoquinoline derivatives
12/23/2009CN101611011A Chemical compounds
12/23/2009CN101611009A Quinoline derivatives
12/23/2009CN101611008A Modulators of C3A receptor and methods of use thereof
12/23/2009CN101611007A Novel JNK inhibitors
12/23/2009CN101611002A 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
12/23/2009CN101610998A 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands
12/23/2009CN101607958A Quinazoline compounds
12/23/2009CN101607957A Intermediate for preparing 3-halo-4,5-dihydro-1h-pyrazoles
12/23/2009CN101607956A Method for splitting chiral medicine of hydrochloric acid lomefloxacin
12/23/2009CN101606522A N-aroyl tetrahydropyrimidine insecticide and preparation method thereof
12/23/2009CN100572379C Cgrp receptor antagonists
12/23/2009CN100572378C Improved cinepazide maleate preparation method
12/23/2009CN100572377C Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder
12/23/2009CN100572376C Imidazole derivatives used as TAFIA inhibitors
12/23/2009CN100572360C Isoquinoline compound and its salt preparation method and application
12/23/2009CA2728476A1 Heterocyclic compound and use thereof
12/23/2009CA2728408A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
12/23/2009CA2728373A1 Aryl ketone as mri
12/23/2009CA2728205A1 Substituted 1-(diazinyl)pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
12/23/2009CA2728156A1 Pyridone compounds
12/23/2009CA2728058A1 Process for the manufacture of an intermediate
12/23/2009CA2728054A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009CA2727251A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009CA2726611A1 Process for the preparation of rho-kinase inhibitor compounds
12/23/2009CA2726508A1 Pyridine compounds
12/23/2009CA2726164A1 Wnt protein signalling inhibitors
12/23/2009CA2725934A1 Novel substituted indoles
12/23/2009CA2725657A1 Novel heteroaryl carboxamide derivatives
12/23/2009CA2725481A1 Nicotinamide derivatives
12/23/2009CA2725014A1 Inhibitors of pi3 kinase
12/22/2009US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide
12/22/2009US7635774 Benzimidazole derivatives
12/22/2009US7635706 5HT4-antagonistic 4-(aminomethyl)-piperidine benzamides
12/22/2009US7635705 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
12/22/2009US7635703 as tyrosine, serine/threonine, cyclin-dependent kinases, HER protein; 5-{2-[3-[4-trifluoromethyl-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-2-yl]-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazol-4-yl]-vinyl}-pyridine-3-carbaldehyde; antiproliferative, antiinflammatory agent, neurodegenerative diseases
12/22/2009US7635702 Imidazole compounds as transforming growth factor (TGF) inhibitors
12/22/2009US7635701 Pyrimidine derivatives and their use as CB2 modulators
12/22/2009US7635694 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
12/22/2009US7635664 For controlling undesirable plants
12/22/2009CA2535614C Quinazoline analogs as receptor tyrosine kinase inhibitors
12/22/2009CA2529032C Processes for the preparation of 1-[2-benzimidazol-1-yl) quinolin-8-yl] piperidin-4-ylamine derivatives
12/22/2009CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/22/2009CA2487306C Novel piperidine compound
12/22/2009CA2450142C Direct binding assay for identifying inhibitors of hcv polymerase
12/22/2009CA2434813C Imidazole derivatives
12/22/2009CA2362381C Amide compounds and medicinal use thereof
12/22/2009CA2346847C Novel imidazoles with anti-inflammatory activity
12/22/2009CA2307879C Treatment of t-helper cell type 2 mediated immune diseases
12/22/2009CA2290744C Cyclic diamine compounds and medicine containing the same
12/22/2009CA2262435C Preparation of sterically hindered amine ethers
12/17/2009WO2009151599A1 Substituted pyrroles and methods of use
12/17/2009WO2009151561A2 Methods and compounds for antimicrobial intervention
12/17/2009WO2009150614A1 Tetrazole compounds as orexin receptor antagonists
12/17/2009WO2009150462A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
12/17/2009WO2009150387A1 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
12/17/2009WO2009150230A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009WO2009150129A1 Heterocyclic derivatives as hdac inhibitors
12/17/2009WO2009150110A1 Pyrrolidine ether derivatives as nk3 receptor antagonists
12/17/2009WO2009150109A1 Imidazolidine derivatives
12/17/2009WO2009149858A1 Novel heteroaromatic amides and thioamides as pesticides
12/17/2009WO2009149837A1 Substituted 4- (indazolyl) -1,4-dihydropyridines and methods of use thereof
12/17/2009WO2009149649A1 Aralkyl alcohol piperidine derivative and the use as medicament for treating depression thereof
12/17/2009WO2009109867A3 Crystal form of phenylamino pyrimidine derivative
1 ... 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 ... 1080